Filing Details
- Accession Number:
- 0001127602-15-013283
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-04-01 20:35:17
- Reporting Period:
- 2015-03-30
- Filing Date:
- 2015-04-01
- Accepted Time:
- 2015-04-01 20:35:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
920148 | Laboratory Corp Of America Holdings | LH | Services-Medical Laboratories (8071) | 133757370 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1457713 | E Mark Brecher | 531 South Spring Street Burlington NC 27215 | Cmo, Labcorp Diagnostics | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-03-30 | 519 | $0.00 | 7,108 | No | 4 | A | Direct | |
Common Stock | Disposition | 2015-03-30 | 172 | $127.28 | 6,936 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2015-03-30 | 11,600 | $90.74 | 18,536 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2015-03-30 | 7,600 | $84.86 | 26,136 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-03-30 | 20,278 | $126.98 | 5,858 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-03-31 | 347 | $127.00 | 5,511 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Options | Disposition | 2015-03-30 | 11,600 | $0.00 | 11,600 | $90.74 |
Common Stock | Non-qualified Stock Options | Disposition | 2015-03-30 | 7,600 | $0.00 | 7,600 | $84.86 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2012-02-09 | 2021-02-09 | No | 4 | M | Direct |
3,800 | 2013-05-24 | 2022-05-23 | No | 4 | M | Direct |
Footnotes
- Shares acquired on March 28, 2015, pursuant to a performance award granted on February 28, 2012, relating to performance during the three-year period ended December 31, 2014.
- Stock withholding to satisfy tax withholding obligations.
- Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
- The price of $126.9815 per share represents a weighted average of sale prices ranging from $126.49 to $127.22 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.
- The option vested in three equal annual installments beginning on the date reflected in this column.
- Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2012 Omnibus Incentive Plan.
- The option vests in three equal annual installments beginning on the date reflected in this column.